In a glioblastoma model, the injection of nanoparticle-formed mRNA encoding interferon regulatory factor 5 and combined with its activating kinase IKKβ can reverse the immunosuppression of tumor-associated macrophages (TAMs) and reprogram them into a phenotype that induces anti-tumor immunity and can promote tumor regression [28]. This evidence concerns the gene IRF5 and neoplasm.